Email Updates

Place quotation marks around exact phrases (e.g. "new york"). Note: Trial names have a space before the number (e.g. HVTN 100).

You are here

Home

Trial Search

Trial Name Prevention Option Phase Start Date Sponsors Countries Population Candidate(s) Status
PSI Private Sector PrEP Program PrEP Open Label November 2016 UNITAID; PSI South Africa Women Planned
Right to Care (DREAMS) PrEP Demo Project PEPFAR, BMGF, Nike Foundation Planned
UNICEF PrEP Demonstration Program PrEP Demo Project November 2016 UNITAID; UNICEF; Brazil Department of Health, Department of STI, AIDS and Viral Hepatitis; Thailand Ministry of Public Health (MOPH), Bureau of AIDS, TB, and STIs; South Africa, National Department of Health (NDoH) South Africa, Brazil, Thailand Planned
Community Health clinic model for Agency in Relationships and Safer Microbicide Adherence (CHARISMA) PrEP Demo Project USAID, RTI International South Africa, Kenya, Zimbabwe, Uganda Women Ongoing
PrEP Adherence Enhancement Guided by iTAB and Drug Levels for Women (AEGiS) PrEP Demo Project January 2016 California HIV/AIDS Research Program of the University of California; Gilead Sciences United States of America Women TDF Planned
Optimization of a Tenofovir Enema for HIV Prevention (DREAM-01) PrEP I June 2016 United States of America Men Planned
Acceptability of HIV Oral PrEP Among MSM and TGW PrEP Open Label January 2016 Chiang Mai University Men Ongoing
CRUSH-PrEP for Women Project PrEP Open Label May 2016 UCSF, Gilead Sciences, Lifelong Medical Care United States of America Ongoing
A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP) PrEP Open Label September 2013 Gilead Sciences Women, Men Ongoing
Partner Services Pre-exposure Prophylaxis (PS-PrEP) PrEP Open Label November 2015 University of Chicago United States of America Men
DISCOVER PrEP III August 2016 Gilead United States of America, Austria, United Kingdom, Denmark, Italy, Spain, Ireland, Germany, Canada, Netherlands MSM F/TAF, F/TDF Ongoing
HIV PrEP Priming of Immune Effectors (PREPPIE) PrEP Open Label January 2016 MRC/UVRI Uganda Research Unit on Aids Uganda Women TDF/FTC (Truvada) Planned
The Queensland Pre-Exposure Prophylaxis Demonstration Project Expansion (QPrEPd) PrEP Demo Project July 2016 Queensland Health/Queensland AIDS Council/University of Queensland Australia Planned
Queensland PrEP Demonstration Project (QPrEP) PrEP Demo Project September 2015 Queensland Health/HIV Foundation Queensland Australia MSM Ongoing
PrEPX PrEP Demo Project July 2016 Victorian Government, Alfred Health and the Victorian AIDS Council Australia Women, Men, MSM Ongoing
Church of Scotland Hospital Demonstration Project PrEP Open Label July 2016 South Africa
HPTN 083 PrEP III, IIb December 2016 NIAID, Viiv Healthcare, Gilead United States of America, Thailand, Brazil, Peru, India, Vietnam, Argentina, South Africa MSM Cabotegravir (GSK 744), TDF/FTC (Truvada) Ongoing
Transgender-Focused PrEP Demo Project - Medical Homes Approach PrEP Demo Project California HIV/AIDS Research Program (CHRP) of the University of California United States of America Planned
Transgender-Focused PrEP Demo Project - Case Management Approach PrEP Demo Project California HIV/AIDS Research Program (CHRP) of the University of California United States of America Planned
Trans Research-Informed Communities United in Mobilization for the Prevention of HIV (TRIUMPH) PrEP Demo Project The California HIV/AIDS Research Program (CHRP) of the University of California United States of America Planned

Pages

CSVDoc